Pulmonary
Partner With Us
Advertisement
Conexiant chevron_right Pulmonary chevron_right Oral Regimens for Rifampin Resistant TB
From the Journals

Oral Regimens for Rifampin-Resistant TB

"The results of the endTB trial improve prospects for effective, simple, all-oral treatment for adults and children with this disease."

Conexiant
article Full Article subject Summary summarize Notecard
  1. The phase III endTB trial confirmed the noninferiority of three all-oral regimens for treating patients with rifampin-resistant tuberculosis.
  2. The trial was conducted in multiple countries, including high-burden TB settings.
  3. The BCLLfxZ, BLMZ, and BDLLfxZ regimens were the most efficacious vs standard therapy.
  4. "The results of the endTB trial improve prospects for effective, simple, all-oral treatment for adults and children with this disease," study authors concluded. 

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.